Abstract
Most data on outcomes in Idiopathic Pulmonary Fibrosis (IPF) pre-dates current guidelines. Data on rates of infection is sparse; the effect of low-dose corticosteroids and disease severity is unknown.
Original language | English |
---|---|
Pages (from-to) | 376-87 |
Number of pages | 12 |
Journal | Respiratory Medicine |
Volume | 108 |
Issue number | 2 |
DOIs | |
Publication status | Published - Feb 2014 |